SK10922000A3 - Triazolopyridazínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents
Triazolopyridazínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie Download PDFInfo
- Publication number
- SK10922000A3 SK10922000A3 SK1092-2000A SK10922000A SK10922000A3 SK 10922000 A3 SK10922000 A3 SK 10922000A3 SK 10922000 A SK10922000 A SK 10922000A SK 10922000 A3 SK10922000 A3 SK 10922000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- methyl
- pyridazine
- triazolo
- triazol
- ylmethoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9801233.9A GB9801233D0 (en) | 1998-01-21 | 1998-01-21 | Therapeutic agents |
GBGB9821517.1A GB9821517D0 (en) | 1998-10-02 | 1998-10-02 | Therapeutic agents |
PCT/GB1999/000103 WO1999037644A1 (en) | 1998-01-21 | 1999-01-13 | Triazolo-pyridazine derivatives as ligands for gaba receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
SK10922000A3 true SK10922000A3 (sk) | 2001-03-12 |
Family
ID=26312988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1092-2000A SK10922000A3 (sk) | 1998-01-21 | 1999-01-13 | Triazolopyridazínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie |
Country Status (24)
Country | Link |
---|---|
US (2) | US6579875B1 (cs) |
EP (1) | EP1049696A1 (cs) |
JP (1) | JP2002501066A (cs) |
KR (1) | KR20010034257A (cs) |
CN (1) | CN1110498C (cs) |
AU (1) | AU748737B2 (cs) |
BG (1) | BG104671A (cs) |
BR (1) | BR9906905A (cs) |
CA (1) | CA2315763A1 (cs) |
CZ (1) | CZ290883B6 (cs) |
EA (1) | EA002755B1 (cs) |
EE (1) | EE200000430A (cs) |
GE (1) | GEP20032868B (cs) |
HR (1) | HRP20000492A2 (cs) |
HU (1) | HUP0100575A3 (cs) |
IL (1) | IL136442A0 (cs) |
IS (1) | IS5540A (cs) |
MX (1) | MXPA00007135A (cs) |
NO (1) | NO315516B1 (cs) |
NZ (1) | NZ504870A (cs) |
PL (1) | PL341652A1 (cs) |
SK (1) | SK10922000A3 (cs) |
WO (1) | WO1999037644A1 (cs) |
YU (1) | YU43800A (cs) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999037644A1 (en) * | 1998-01-21 | 1999-07-29 | Merck Sharp & Dohme Limited | Triazolo-pyridazine derivatives as ligands for gaba receptors |
GB9929685D0 (en) | 1999-12-15 | 2000-02-09 | Merck Sharp & Dohme | Therapeutic agents |
GB0017543D0 (en) * | 2000-07-17 | 2000-09-06 | Merck Sharp & Dohme | Therapeutic agents |
WO2005058860A1 (ja) * | 2003-12-19 | 2005-06-30 | Ube Industries, Ltd. | 4−置換又は非置換テトラヒドロピラン−4−カルボン酸化合物又はそのエステル化合物の製法 |
EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
CA2625210A1 (en) * | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
AP3433A (en) * | 2005-12-21 | 2015-10-31 | Janssen Pharmaceutica Nv | Triazolopyridazines as tyrosine kinase modultors |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
WO2007134136A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
AU2007249435A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
KR20090064418A (ko) | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
EP2123619A1 (de) | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma AG | Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung |
EA020071B1 (ru) * | 2008-08-29 | 2014-08-29 | Консерт Фармасьютикалс Инк. | Замещенные производные триазолопиридазина |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
JP2012531419A (ja) * | 2009-06-23 | 2012-12-10 | コンサート ファーマシューティカルズ インコーポレイテッド | Gaba−a受容体修飾物質としての重水素修飾されたトリアゾロピリダジン誘導体 |
DK2464645T3 (en) | 2009-07-27 | 2017-10-23 | Gilead Sciences Inc | CONDENSED, HETEROCYCLIC COMPOUNDS AS IRON CHANNEL MODULATORS |
WO2012050907A2 (en) | 2010-09-28 | 2012-04-19 | The Regents Of The University Of California | Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes |
AU2012253653A1 (en) | 2011-05-10 | 2013-05-02 | Gilead Sciences, Inc. | Fused heterocyclic compounds as sodium channel modulators |
NO3175985T3 (cs) | 2011-07-01 | 2018-04-28 | ||
UY34171A (es) | 2011-07-01 | 2013-01-31 | Gilead Sciences Inc | Compuestos heterocíclicos fusionados como moduladores del canal iónico |
GB201321745D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
WO2017151617A1 (en) | 2016-02-29 | 2017-09-08 | Dana-Farber Cancer Institute, Inc. | Stapled intracellular-targeting antimicrobial peptides to treat infection |
CN107344936B (zh) * | 2016-05-06 | 2022-06-03 | 上海赛默罗生物科技有限公司 | 三唑哒嗪类衍生物、其制备方法、药物组合物和用途 |
US11325955B2 (en) | 2017-07-19 | 2022-05-10 | Dana-Farber Cancer Institute, Inc. | Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1080712A (en) * | 1976-09-22 | 1980-07-01 | Jay D. Albright | Hypotensive agents |
US4230705A (en) | 1976-09-22 | 1980-10-28 | American Cyanamid Company | 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety |
US4112095A (en) * | 1976-10-07 | 1978-09-05 | American Cyanamid Company | 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents |
PH12424A (en) * | 1976-10-26 | 1979-02-15 | American Cyanamid Co | Method of treating anxiety in mammals |
US4260755A (en) | 1979-10-31 | 1981-04-07 | American Cyanamid Company | Novel 6-phenyl and substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines |
US4260756A (en) | 1979-11-15 | 1981-04-07 | American Cyanamid Company | 6- And 8-heteroaryl-1,2,4-triazolo[4,3-b]pyridazines |
PH21834A (en) * | 1982-01-18 | 1988-03-17 | Lepetit Spa | New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives |
IT1194310B (it) * | 1983-07-12 | 1988-09-14 | Lepetit Spa | Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti |
US4654343A (en) | 1985-10-31 | 1987-03-31 | American Cyanamid Company | N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas |
US6255305B1 (en) | 1996-07-25 | 2001-07-03 | Merck Sharp & Dohme Limited | Substituted triazolo-pyridazine derivatives as ligands for GABA receptors |
WO1999037644A1 (en) | 1998-01-21 | 1999-07-29 | Merck Sharp & Dohme Limited | Triazolo-pyridazine derivatives as ligands for gaba receptors |
-
1999
- 1999-01-13 WO PCT/GB1999/000103 patent/WO1999037644A1/en not_active Application Discontinuation
- 1999-01-13 SK SK1092-2000A patent/SK10922000A3/sk unknown
- 1999-01-13 CZ CZ20002691A patent/CZ290883B6/cs not_active IP Right Cessation
- 1999-01-13 HU HU0100575A patent/HUP0100575A3/hu unknown
- 1999-01-13 IL IL13644299A patent/IL136442A0/xx unknown
- 1999-01-13 CA CA002315763A patent/CA2315763A1/en not_active Abandoned
- 1999-01-13 EP EP99901025A patent/EP1049696A1/en not_active Withdrawn
- 1999-01-13 MX MXPA00007135A patent/MXPA00007135A/es unknown
- 1999-01-13 BR BR9906905-9A patent/BR9906905A/pt not_active IP Right Cessation
- 1999-01-13 GE GEAP19995511A patent/GEP20032868B/en unknown
- 1999-01-13 YU YU43800A patent/YU43800A/sh unknown
- 1999-01-13 KR KR1020007007937A patent/KR20010034257A/ko not_active Application Discontinuation
- 1999-01-13 PL PL99341652A patent/PL341652A1/xx not_active Application Discontinuation
- 1999-01-13 EA EA200000783A patent/EA002755B1/ru not_active IP Right Cessation
- 1999-01-13 JP JP2000528565A patent/JP2002501066A/ja not_active Withdrawn
- 1999-01-13 CN CN99802249A patent/CN1110498C/zh not_active Expired - Fee Related
- 1999-01-13 AU AU20657/99A patent/AU748737B2/en not_active Ceased
- 1999-01-13 US US09/582,589 patent/US6579875B1/en not_active Expired - Fee Related
- 1999-01-13 NZ NZ504870A patent/NZ504870A/xx unknown
- 1999-01-13 EE EEP200000430A patent/EE200000430A/xx unknown
-
2000
- 2000-06-16 IS IS5540A patent/IS5540A/is unknown
- 2000-07-20 NO NO20003730A patent/NO315516B1/no not_active IP Right Cessation
- 2000-07-21 HR HR20000492A patent/HRP20000492A2/hr not_active Application Discontinuation
- 2000-08-07 BG BG104671A patent/BG104671A/xx unknown
-
2003
- 2003-06-17 US US10/463,075 patent/US6828322B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EA002755B1 (ru) | 2002-08-29 |
WO1999037644A1 (en) | 1999-07-29 |
AU2065799A (en) | 1999-08-09 |
NZ504870A (en) | 2002-11-26 |
EP1049696A1 (en) | 2000-11-08 |
AU748737B2 (en) | 2002-06-13 |
US20040063714A1 (en) | 2004-04-01 |
MXPA00007135A (es) | 2002-11-07 |
CN1110498C (zh) | 2003-06-04 |
BR9906905A (pt) | 2000-10-10 |
KR20010034257A (ko) | 2001-04-25 |
CA2315763A1 (en) | 1999-07-29 |
CZ290883B6 (cs) | 2002-11-13 |
NO315516B1 (no) | 2003-09-15 |
JP2002501066A (ja) | 2002-01-15 |
HRP20000492A2 (en) | 2000-12-31 |
PL341652A1 (en) | 2001-04-23 |
HUP0100575A2 (hu) | 2001-09-28 |
IS5540A (is) | 2000-06-16 |
EE200000430A (et) | 2001-12-17 |
US6828322B2 (en) | 2004-12-07 |
US6579875B1 (en) | 2003-06-17 |
IL136442A0 (en) | 2001-06-14 |
GEP20032868B (en) | 2003-01-27 |
NO20003730L (no) | 2000-09-20 |
BG104671A (en) | 2001-05-31 |
CN1288465A (zh) | 2001-03-21 |
EA200000783A1 (ru) | 2000-12-25 |
NO20003730D0 (no) | 2000-07-20 |
YU43800A (sh) | 2002-12-10 |
HUP0100575A3 (en) | 2003-03-28 |
CZ20002691A3 (cs) | 2000-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK10922000A3 (sk) | Triazolopyridazínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie | |
US6500828B1 (en) | Triazolo-pyridazine derivatives as ligands for gaba receptors | |
EA021504B1 (ru) | Производные 1-гетероциклил-1,5-дигидропиразоло[3,4-d]пиримидин-4-она и их применение в качестве модуляторов pde9a | |
JP2004501109A (ja) | Gaba受容体に対するリガンドとしての3−フェニル−イミダゾ−ピリミジン誘導体 | |
WO2002081474A1 (en) | Triazolophthalazine / quinoline / isoquinoline derivatives which are ligands for gaba-a receptors containing the alpha 5 subtype | |
JP2002501067A (ja) | Gaba受容体に対するリガンドとしてのトリアゾロ−ピリダジン誘導体 | |
US6303605B1 (en) | Triazolo-pyridazine derivatives as ligands for GABA receptors | |
EP1212324B1 (en) | Imidazo-triazine derivatives as ligands for gaba receptors | |
US6337331B1 (en) | Triazolo-pyrimidine as ligands for GABA receptors | |
US6303597B1 (en) | Triazolo-pyridazine derivatives as ligands for GABA receptors | |
US6291460B1 (en) | Triazolo-pyridazine derivatives as ligands for GABA receptors | |
US20040192692A1 (en) | 5-Phenyl[1,2,4]triazines as ligands for GABA-A alpha2/alpha3 receptors for treating anxiety or depression | |
US6297235B1 (en) | Triazolopyridazine derivatives for treating anxiety and enhancing cognition | |
EP1532136A1 (en) | Pyridazine derivatives as ligands for gaba receptors | |
US6699859B1 (en) | Triazolo-pyridazine derivatives as ligands for GABA receptors | |
US6444666B1 (en) | Triazolopyridazine Derivatives for treating anxiety and enhancing cognition |